Oncolys BioPharma, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3202170001
JPY
1,061.00
124 (13.23%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
2,752.21
1,474.10
2,159.27
3,593.99
2,003.33
3,454.05
Shareholder's Funds
2,752.21
1,474.10
2,159.27
3,593.99
2,003.33
3,454.05
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
304.61
296.44
386.90
497.10
518.80
519.80
Secured Loans
304.61
296.44
386.90
497.10
518.80
519.80
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Other Long Term Liabilities
27.6
26.87
14.51
12.13
11.2
13.32
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
7.57
8.14
7.75
5.76
4.92
4.91
Total Non-Current Liabilities
194.26
187.97
170.05
267.67
377.84
402.20
Current Liabilities
Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
7.57
8.14
7.75
5.76
4.92
4.91
Total Current Liabilities
252.39
378.53
321.64
430.21
415.24
523.80
Total Liabilities
3,198.86
2,040.60
2,650.96
4,291.88
2,796.41
4,380.05
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
71.83
71.02
68.73
67.82
90.32
76.47
Less: Accumulated Depreciation
71.83
71.02
68.73
67.82
69.00
64.64
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
0.00
0.00
0.00
0.00
21.32
11.82
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
68.48
63.59
21.04
55.54
143.52
430.59
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
22.18
20.99
21.17
21.24
21.25
27.55
Total Non-Current Assets
100.61
84.71
42.20
93.87
250.74
553.63
Current Assets Loans & Advances
Current Investments
245.08
245.08
245.08
245.08
245.08
245.07
Inventories
4.58
5.34
24.25
11.66
10.47
14.92
Sundry Debtors
0.00
0.00
0.00
352.15
70.60
169.31
Cash and Bank
2,165.92
1,287.76
1,466.20
3,209.64
1,822.85
3,097.51
Other Current Assets
2,563.83
1,639.93
2,053.94
3,843.00
2,245.99
3,574.84
Short Term Loans and Advances
0.00
0.00
318.40
24.48
96.99
48.02
Total Current Assets
3,098.24
1,955.88
2,608.75
4,198.01
2,545.68
3,826.43
Net Current Assets (Including Current Investments)
2,845.85
1,577.35
2,287.11
3,767.80
2,130.43
3,302.63
Total Current Assets Excluding Current Investments
3,098.24
1,955.88
2,608.75
4,198.01
2,545.68
3,826.43
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
3,198.86
2,040.60
2,650.96
4,291.88
2,796.41
4,380.06
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
304.61
296.44
386.90
497.10
518.80
519.80
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Dec 2024 is 3.45% vs 3.57% in Dec 2023

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Dec 2024 is 2.72% vs 85.18% in Dec 2023

stock-summary

Fixed Assets

No Fixed Assets in the last few periods;

stock-summary

Investments

YoY Growth in year ended Dec 2024 is 7.69% vs 202.23% in Dec 2023

stock-summary

Current Assets

YoY Growth in year ended Dec 2024 is 58.41% vs -25.03% in Dec 2023

Compare Balance Sheet Results of Oncolys BioPharma, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
2,752.21
2,475.35
276.86
11.18%
Shareholder's Funds
2,752.21
2,475.35
276.86
11.18%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
304.61
36.51
268.10
734.32%
Secured Loans
304.61
36.51
268.10
734.32%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
1.27
-1.27
-100.00%
Other Long Term Liabilities
27.60
65.38
-37.78
-57.79%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
7.57
39.29
-31.72
-80.73%
Total Non-Current Liabilities
194.26
73.79
120.47
163.26%
Current Liabilities
Trade Payables
0
2.00
-2.00
-100.00%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
7.57
39.29
-31.72
-80.73%
Total Current Liabilities
252.39
222.97
29.42
13.19%
Total Liabilities
3,198.86
2,772.11
426.75
15.39%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
71.83
978.13
-906.30
-92.66%
Less: Accumulated Depreciation
71.83
978.13
-906.30
-92.66%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
0.00
0.00
0.00
0.00%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
68.48
0
68.48
0.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
22.18
34.40
-12.22
-35.52%
Total Non-Current Assets
100.61
34.40
66.21
192.47%
Current Assets Loans & Advances
Current Investments
245.08
0
245.08
0.00%
Inventories
4.58
154.15
-149.57
-97.03%
Sundry Debtors
0
87.09
-87.09
-100.00%
Cash and Bank
2,165.92
2,108.48
57.44
2.72%
Other Current Assets
2,563.83
2,349.72
214.11
9.11%
Short Term Loans and Advances
0
0
0.00
0.00%
Total Current Assets
3,098.24
2,737.72
360.52
13.17%
Net Current Assets (Including Current Investments)
2,845.85
2,514.75
331.10
13.17%
Total Current Assets Excluding Current Investments
3,098.24
2,737.72
360.52
13.17%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
3,198.86
2,772.11
426.75
15.39%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
304.61
36.51
268.10
734.32%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 166.66 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 3.45% vs 3.57% in Dec 2023

Annual - Other Long Term Liabilities
Other Long Term Liabilities 27.60 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 2.72% vs 85.18% in Dec 2023

Annual - Fixed Assets
Fixed Assets 0.00 Million
in Dec 2024

Figures in Million
stock-summary

No Fixed Assets in the last few periods;

Annual - Investments
Investments 68.48 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 7.69% vs 202.23% in Dec 2023

Annual - Current Assets
Current Assets 3,098.24 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 58.41% vs -25.03% in Dec 2023